Bristol-Myers Squibb Company (BMY) Submits New Drug Application To FDA For A Fixed-Dose Combination Tablet Of Atazanavir Sulfate With Cobicistat For People Living With HIV-1
4/14/2014 9:36:33 AM
More...
|
Bristol-Myers Squibb Company (BMY) Submits NDAs For Daclatasvir And Asunaprevir To The FDA For Hepatitis C Drugs
4/7/2014 6:50:56 AM
More...
|
Bristol-Myers Squibb Company (BMY) To Present Data For Daclatasvir In Multiple Investigational All-Oral Combinations Across Hepatitis C Genotypes At The International Liver Congress™
3/24/2014 8:25:18 AM
More...
|
Five Prime Therapeutics, Inc. (FPRX), Bristol-Myers Squibb Company (BMY) Strike $350 Million Immuno-Oncology Pact
3/17/2014 6:54:22 AM
More...
|
Bristol-Myers Squibb Company (BMY)/Pfizer Inc. (PFE) Release: FDA Approves Eliquis® (Apixaban) To Reduce The Risk Of Blood Clots Following Hip Or Knee Replacement Surgery
3/14/2014 1:13:59 PM
More...
|
Bristol-Myers Squibb Company (BMY) Announces Dividend
3/4/2014 8:57:28 AM
More...
|
Bristol-Myers Squibb Company (BMY) Announces Charitable Donation Of $1 Million To Support Immuno-Oncology Education For Patients And Caregivers
3/3/2014 8:20:47 AM
More...
|
Clinical Trials Initiated For A New Molecule Jointly Identified By IRIC And Bristol-Myers Squibb Company (BMY)
2/26/2014 9:35:18 AM
More...
|
FDA Approves Bristol-Myers Squibb Company (BMY)' Drug For Rare Fat Disorder
2/25/2014 7:22:51 AM
More...
|
Bristol-Myers Squibb Company (BMY) And Pfizer Inc. (PFE) Release: In a Subanalysis, Eliquis® (apixaban) Reduced The Risk of Stroke And Demonstrated Fewer Major Bleeding Events Versus Warfarin Consistently Across Age Groups, Including Older Patients With Nonvalvular Atrial Fibrillation
2/21/2014 9:13:43 AM
More...
|
|